Marapharm Ventures Inc. announces $4,633,348.00 of warrants exercised

ID: 1520265
recent pressrelease next pressrelease

(businesspress24) - Marapharm Ventures Inc. announces $4,633,348.00 of warrants exercised

News Release ---
September 11th, 2017 Kelowna, BC

Marapharm Ventures Inc. "Marapharm" announces that $4,633,348.00 has been received from the exercise of warrants. The warrants were issued in a unit offering containing 1 common share and 1 share purchase warrant. The right to exercise the warrants expired on September 6, 2017 at 5 pm PST.

"We are very pleased that our shareholders continue to show confidence in Marapharm as evidenced by the exercise of their warrants. Ongoing working capital, including the $4,633,348.00 from the warrants, is essential to the Marapharm brand as the company builds out cannabis operations in 3 US States. Marapharm facilities will incorporate state of the art security and environmental standards. Compliance elements are of the highest concern and are being built into every operational element." Linda Sampson, Marapharm CEO.

There are no more unit offerings with warrants to be exercised at this time; however, there is a "warrant only" offering announced August 8, 2017 still outstanding.


Marapharm is a publicly traded company on the Canadian Stock Exchange investing in the medical and recreational cannabis space, with corporate operations based in British Columbia, Canada. Since 2016 they have rapidly expanded their footprint to include production locations in the key North American states of Washington, Nevada, and California. They actively seek expansion opportunities worldwide.

FOR FURTHER INFORMATION: or Linda Sampson, CEO 778-583-4476 email info(at)


Marapharm trades in Canada, ticker symbol MDM on the CSE, in the United States, ticker symbol MRPHF on the OTCQB, in Europe, ticker symbol 2Mo on the FSE. Marapharm also trades on other recognized platforms in Europe including Stuttgart, Tradegate, L & S, Quotnx, Dusseldork, Munich, and Berlin.

Neither the CSE, the FSE nor the OTCQB® has approved nor disapproved the contents of this press release. Neither the CSE, the FSE nor the OTCQB® accepts responsibility for the adequacy or accuracy of this release.

FSE: 2M0 ----

Certain statements contained in this news release constitute forward looking statements. The use of any of the words anticipate, continue, estimate, expect, may, will, project, should, believe, and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements are based on reasonable assumption but no assurance can be given that these expectations will prove to be correct and the forward-looking statements included in this news release should not be unduly relied upon.

More information:

Keywords (optional):

Company information / Profile:

PressRelease by


PressContact / Agency:

published by: irw
print pressrelease  send to a friend  

Date: 09/11/2017 - 01:43
Language: English
News-ID 1520265
Character count: 2905
Firma: Marapharm Ventures Inc.
Ansprechpartner: Feedback to about Pressrelease-id:
Stadt: Wien


Number of hits: 282


Direct Link to this PressRelease:

We would appreciate a link in your News-, Press- or Partner-Site.

Comments on this PressRelease

All members: 9 211
Register today: 1
Register yesterday: 0
Members online: 1
Guests online: 61

Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.